Table of Contents
Journal of Signal Transduction
Volume 2012 (2012), Article ID 414913, 13 pages
http://dx.doi.org/10.1155/2012/414913
Review Article

Functional Mechanisms and Roles of Adaptor Proteins in Abl-Regulated Cytoskeletal Actin Dynamics

1Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan
2Institute of Microbial Diseases, Osaka University, Osaka 565-0871, Japan
3Laboratory of Single-Molecule Cell Biology, Tohoku University Graduate School of Life Sciences, Aoba-ku, Sendai, Miyagi 980-8578, Japan

Received 16 February 2012; Accepted 16 March 2012

Academic Editor: A. Yoshimura

Copyright © 2012 Mizuho Sato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Plattner, L. Kadlec, K. A. Demali, A. Kazlauskas, and A. M. Pendergast, “c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF,” Genes and Development, vol. 13, no. 18, pp. 2400–2411, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Y. Ting, K. H. Kain, R. L. Klemke, and R. Y. Tsien, “Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15003–15008, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Mayer, “SH3 domains: complexity in moderation,” Journal of Cell Science, vol. 114, no. 7, pp. 1253–1263, 2001. View at Google Scholar · View at Scopus
  4. P. J. Woodring, T. Hunter, and J. Y. J. Wang, “Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases,” Journal of Cell Science, vol. 116, no. 13, pp. 2613–2626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. W. D. Bradley and A. J. Koleske, “Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts,” Journal of Cell Science, vol. 122, no. 19, pp. 3441–3454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Colicelli, “ABL tyrosine kinases: evolution of function, regulation, and specificity,” Science Signaling, vol. 3, no. 139, article re6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Woodring, E. David Litwack, D. D. M. O'Leary, G. R. Lucero, J. Y. J. Wang, and T. Hunter, “Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension,” Journal of Cell Biology, vol. 156, no. 5, pp. 879–892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Pluk, K. Dorey, and G. Superti-Furga, “Autoinhibition of c-Abl,” Cell, vol. 108, no. 2, pp. 247–259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Nagar, O. Hantschel, M. A. Young et al., “Structural basis for the autoinhibition of c-Abl tyrosine kinase,” Cell, vol. 112, no. 6, pp. 859–871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Chen, L. P. O'Reilly, T. E. Smithgall, and J. R. Engen, “Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core,” Journal of Molecular Biology, vol. 383, no. 2, pp. 414–423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Chen, T. P. Dumitrescu, T. E. Smithgall, and J. R. Engen, “Abl N-terminal cap stabilization of SH3 domain dynamics,” Biochemistry, vol. 47, no. 21, pp. 5795–5803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Filippakopoulous, S. Muller, and S. Knapp, “SH2 domains: modulators of nonreceptor tyrosine kinase activity,” Current Opinion in Structural Biology, vol. 19, no. 6, pp. 643–649, 2009. View at Publisher · View at Google Scholar
  13. S. P. Goff, E. Gilboa, O. N. Witte, and D. Baltimore, “Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA,” Cell, vol. 22, no. 3, pp. 777–785, 1980. View at Google Scholar · View at Scopus
  14. E. P. Reddy, M. J. Smith, and A. Srinivasan, “Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 12, pp. 3623–3627, 1983. View at Google Scholar · View at Scopus
  15. J. Y. J. Wang, F. Ledley, S. Goff, R. Lee, Y. Groner, and D. Baltimore, “The mouse c-abl locus: molecular cloning and characterization,” Cell, vol. 36, no. 2, pp. 349–356, 1984. View at Google Scholar · View at Scopus
  16. J. B. Konopka, S. M. Watanabe, J. W. Singer, S. J. Collins, and O. N. Witte, “Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 6, pp. 1810–1814, 1985. View at Google Scholar · View at Scopus
  17. Y. Ben-Neriah, G. Q. Daley, A. M. Mes-Masson, O. N. Witte, and D. Baltimore, “The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene,” Science, vol. 233, no. 4760, pp. 212–214, 1986. View at Google Scholar · View at Scopus
  18. G. D. Kruh, R. Perego, T. Miki, and S. A. Aaronson, “The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 15, pp. 5802–5806, 1990. View at Google Scholar
  19. H. Hoffman-Falk, P. Einat, B. Shilo, and F. Hoffmann, “Drosophila melanogaster DNA clones homologous to vertebrate oncogenes: evidence for a common ancestor to the src and abl cellular genes,” Cell, vol. 32, no. 2, pp. 589–598, 1983. View at Google Scholar
  20. J. M. Goddard, J. J. Weiland, and M. R. Capecchi, “Isolation and characterization of Caenorhabditis elegans DNA sequences homologous to the v-abl oncogene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 7, pp. 2172–2176, 1986. View at Google Scholar · View at Scopus
  21. P. L. Schwartzberg, A. M. Stall, J. D. Hardin et al., “Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations,” Cell, vol. 65, no. 7, pp. 1165–1175, 1991. View at Google Scholar · View at Scopus
  22. V. L. J. Tybulewicz, C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan, “Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene,” Cell, vol. 65, no. 7, pp. 1153–1163, 1991. View at Google Scholar · View at Scopus
  23. H. Brightbill and M. S. Schlissel, “The effects of c-Abl mutation on developing B cell differentiation and survival,” International Immunology, vol. 21, no. 5, pp. 575–585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Liberatore and S. P. Goff, “c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation,” International Immunology, vol. 21, no. 4, pp. 403–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Silberman, R. V. Sionov, V. Zuckerman et al., “T cell survival and function requires the c-Abl tyrosine kinase,” Cell Cycle, vol. 7, no. 24, pp. 3847–3857, 2008. View at Google Scholar · View at Scopus
  26. B. Li, S. Boast, K. de los Santos et al., “Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation,” Nature Genetics, vol. 24, no. 3, pp. 304–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Koleske, A. M. Gifford, M. L. Scott et al., “Essential roles for the Abl and Arg tyrosine kinases in neurulation,” Neuron, vol. 21, no. 6, pp. 1259–1272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Srinivasan and R. Plattner, “Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells,” Cancer Research, vol. 66, no. 11, pp. 5648–5655, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. T. P. Newsome, I. Weisswange, F. Frischknecht, and M. Way, “Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus,” Cellular Microbiology, vol. 8, no. 2, pp. 233–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Backert, S. M. Feller, and S. Wessler, “Emerging roles of Abl family tyrosine kinases in microbial pathogenesis,” Trends in Biochemical Sciences, vol. 33, no. 2, pp. 80–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. R. Mcwhirter and J. Y. J. Wang, “An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias,” The EMBO Journal, vol. 12, no. 4, pp. 1533–1546, 1993. View at Google Scholar · View at Scopus
  32. R. A. van Etten, P. K. Jackson, D. Baltimore, M. C. Sanders, P. T. Matsudaira, and P. A. Janmey, “The COOH terminus of the c-abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity,” Journal of Cell Biology, vol. 124, no. 3, pp. 325–340, 1994. View at Google Scholar · View at Scopus
  33. Y. Wang, A. L. Miller, M. S. Mooseker, and A. J. Koleske, “The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 14865–14870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. E. T. Kipreos and J. Y. J. Wang, “Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA,” Science, vol. 256, no. 5055, pp. 382–385, 1992. View at Google Scholar · View at Scopus
  35. M. H. David-Cordonnier, M. Hamdane, C. Bailly, and J. C. D'Halluin, “Determination of the human c-Abl consensus DNA binding site,” The FEBS Letters, vol. 424, no. 3, pp. 177–182, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. B. R. Henderson and A. Eleftheriou, “A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals,” Experimental Cell Research, vol. 256, no. 1, pp. 213–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Taagepera, D. Mcdonald, J. E. Loeb et al., “Nuclear-cytoplasmic shuttling of c-Abl tyrosine kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7457–7462, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Shaul, “c-Abl: activation and nuclear targets,” Cell Death and Differentiation, vol. 7, no. 1, pp. 10–16, 2000. View at Google Scholar · View at Scopus
  39. J. Y. J. Wang, “Regulation of cell death by the Abl tyrosine kinase,” Oncogene, vol. 19, no. 49, pp. 5643–5650, 2000. View at Google Scholar · View at Scopus
  40. J. M. Lewis, R. Baskaran, S. Taagepera, M. A. Schwartz, and J. Y. J. Wang, “Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 26, pp. 15174–15179, 1996. View at Google Scholar · View at Scopus
  41. R. A. van Etten, P. Jackson, and D. Baltimore, “The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization,” Cell, vol. 58, no. 4, pp. 669–678, 1989. View at Google Scholar · View at Scopus
  42. A. M. Mes-Masson, J. McLaughlin, G. Q. Daley, M. Paskind, and O. N. Witte, “Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, pp. 9768–9772, 1986. View at Google Scholar
  43. T. Takeya and H. Hanafusa, “Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus,” Cell, vol. 32, no. 3, pp. 881–890, 1983. View at Google Scholar · View at Scopus
  44. K. M. Smith, R. Yacobi, and R. A. van Etten, “Autoinhibition of Bcr-Abl through its SH3 domain,” Molecular Cell, vol. 12, no. 1, pp. 27–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Hantschel, B. Nagar, S. Guettler et al., “A myristoyl/phosphotyrosine switch regulates c-Abl,” Cell, vol. 112, no. 6, pp. 845–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Nagar, O. Hantschel, M. Seeliger et al., “Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase,” Molecular Cell, vol. 21, no. 6, pp. 787–798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. B. B. Brasher and R. A. van Etten, “c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines,” The Journal of Biological Chemistry, vol. 275, no. 45, pp. 35631–35637, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Furstoss, K. Dorey, V. Simon, D. Barilà, G. Superti-Furga, and S. Roche, “c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis,” The EMBO Journal, vol. 21, no. 4, pp. 514–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Q. Tanis, D. Veach, H. S. Duewel, W. G. Bornmann, and A. J. Koleske, “Two distinct phosphorylation pathways have additive effects on Abl family kinase activation,” Molecular and Cellular Biology, vol. 23, no. 11, pp. 3884–3896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Derkinderen, T. M. E. Scales, D. P. Hanger et al., “Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase,” Journal of Neuroscience, vol. 25, no. 28, pp. 6584–6593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. B. J. Mayer and D. Baltimore, “Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase,” Molecular and Cellular Biology, vol. 14, no. 5, pp. 2883–2894, 1994. View at Google Scholar · View at Scopus
  52. D. Barila and G. Superti-Furga, “An intramolecular SH3-domain interaction regulates c-Abl activity,” Nature Genetics, vol. 18, no. 3, pp. 280–282, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Meyn III, M. B. Wilson, F. A. Abdi et al., “Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity,” The Journal of Biological Chemistry, vol. 281, no. 41, pp. 30907–30916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. P. J. Woodring, T. Hunter, and J. Y. J. Wang, “Inhibition of c-Abl Tyrosine Kinase Activity by Filamentous Actin,” The Journal of Biological Chemistry, vol. 276, no. 29, pp. 27104–27110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. B. J. Mayer, M. Hamaguchi, and H. Hanafusa, “A novel viral oncogene with structural similarity to phospholipase C,” Nature, vol. 332, no. 6161, pp. 272–275, 1988. View at Google Scholar · View at Scopus
  56. C. T. Reichman, B. J. Mayer, S. Keshav, and H. Hanafusa, “The product of the cellular crk gene consists primarily of SH2 and SH3 regions,” Cell Growth & Differentiation, vol. 3, no. 7, pp. 451–460, 1992. View at Google Scholar · View at Scopus
  57. M. Matsuda, S. Tanaka, S. Nagata, A. Kojima, T. Kurata, and M. Shibuya, “Two species of human CRK cDNA encode proteins with distinct biological activities,” Molecular and Cellular Biology, vol. 12, no. 8, pp. 3482–3489, 1992. View at Google Scholar · View at Scopus
  58. J. Ten Hoeve, C. Morris, N. Heisterkamp, and J. Groffen, “Isolation and chromosomal localization of CRKL, a human crk-like gene,” Oncogene, vol. 8, no. 9, pp. 2469–2474, 1993. View at Google Scholar · View at Scopus
  59. T. Shishido, M. Sato, M. Maruoka, and K. Tani, “Abelson inteactor (Abi) family proteins and cancer,” Adaptor Proteins and Cancer (Ed. M.M. Georgescu), pp. 103–120, 2008. View at Google Scholar
  60. V. L. Goss, K. A. Lee, A. Moritz et al., “A common phosphotyrosine signature for the Bcr-Abl kinase,” Blood, vol. 107, no. 12, pp. 4888–4897, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. Biesova, C. Piccoli, and W. T. Wong, “Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth,” Oncogene, vol. 14, no. 2, pp. 233–241, 1997. View at Google Scholar · View at Scopus
  62. Z. Dai and A. M. Pendergast, “Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity,” Genes and Development, vol. 9, no. 21, pp. 2569–2582, 1995. View at Google Scholar · View at Scopus
  63. B. Wang, E. A. Golemis, and G. D. Kruh, “ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks,” The Journal of Biological Chemistry, vol. 272, no. 28, pp. 17542–17550, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Ribon, R. Herrera, B. K. Kay, and A. R. Saltiel, “A role for CAP, a novel, multifunctional Src homology 3 domain- containing protein in formation of actin stress fibers and focal adhesions,” The Journal of Biological Chemistry, vol. 273, no. 7, pp. 4073–4080, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Mandai, H. Nakanishi, A. Satoh et al., “Ponsin/SH3P12: an 1-afadin- and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions,” Journal of Cell Biology, vol. 144, no. 5, pp. 1001–1017, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Kioka, S. Sakata, T. Kawauchi et al., “Vinexin: a novel vinculin-binding protein with multiple SH3 domains enhances actin cytoskeletal organization,” Journal of Cell Biology, vol. 144, no. 1, pp. 58–69, 1999. View at Google Scholar · View at Scopus
  67. J. M. Smith, S. Katz, and B. J. Mayer, “Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck,” The Journal of Biological Chemistry, vol. 274, no. 39, pp. 27956–27962, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Salgia, M. Sattle, E. Pisick, J. L. Li, and J. D. Griffin, “p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl,” Experimental Hematology, vol. 24, no. 2, pp. 310–313, 1996. View at Google Scholar
  69. S. M. Feller, “CrK family adaptors-signalling complex formation and biological roles,” Oncogene, vol. 20, no. 44, pp. 6348–6371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. R. B. Birge, C. Kalodimos, F. Inagaki, and S. Tanaka, “Crk and CrkL adaptor proteins: networks for physiological and pathological signaling,” Cell Communication and Signaling, vol. 7, article 13, 2009. View at Publisher · View at Google Scholar
  71. Y. Leng, J. Zhang, K. Badour et al., “Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphory lation required for WAVE2 activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 4, pp. 1098–1103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. E. A. Burton, T. N. Oliver, and A. M. Pendergast, “Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway,” Molecular and Cellular Biology, vol. 25, no. 20, pp. 8834–8843, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Echarri, M. J. Lai, M. R. Robinson, and A. M. Pendergast, “Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and Wave-1 levels,” Molecular and Cellular Biology, vol. 24, no. 11, pp. 4979–4993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Y. Lin, C. H. Huang, W. G. Chou, and J. L. Juang, “Abi enhances Abl-mediated Cdc2 phosphorylation and inactivation,” Journal of Biomedical Science, vol. 11, no. 6, pp. 902–910, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Tani, S. Sato, T. Sukezane et al., “Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase,” The Journal of Biological Chemistry, vol. 278, no. 24, pp. 21685–21692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Kobashigawa, M. Sakai, M. Naito et al., “Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK,” Nature Structural and Molecular Biology, vol. 14, no. 6, pp. 503–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Shi, K. Alin, and S. P. Goff, “Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity,” Genes and Development, vol. 9, no. 21, pp. 2583–2597, 1995. View at Google Scholar · View at Scopus
  78. K. Miyazaki, S. Matsuda, Y. Ichigotani et al., “Isolation and characterization of a novel human gene (NESH) which encodes a putative signaing molecule similar to e3B1 proteins,” Biochimica et Biophysica Acta, vol. 1493, no. 1-2, pp. 237–241, 2000. View at Publisher · View at Google Scholar
  79. S. Panigrahi, J. Stetefeld, J. R. Jangamreddy, S. Mandal, S. K. Mandal, and M. Los , “Modeling of molecular interaction between apoptin, Bcr-Abl and CrkL—an alternative approach to conventional rational drug design,” PloS One, vol. 7, no. 1, Article ID e28395, 2012. View at Google Scholar
  80. P. M. Dubielecka, K. I. Ladwein, X. Xiong et al., “Essential role for Abi1 in embryonic survival and WAVE2 complex integrity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 17, pp. 7022–7027, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Ring, M. H. Ginsberg, J. Haling, and A. M. Pendergast, “Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the α4 integrin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 149–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Grove, G. Demyanenko, A. Echarri et al., “Abi2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory,” Molecular and Cellular Biology, vol. 24, no. 24, pp. 10905–10922, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. T. J. Park, K. Boyd, and T. Curran, “Cardiovascular and craniofacial defects in Crk-null mice,” Molecular and Cellular Biology, vol. 26, no. 16, pp. 6272–6282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Shishido and J. Suzuki, “Regulation of Abl kinases by adaptor proteins,” Gene Therapy and Molecular Biology, vol. 19, pp. 339–342, 2005. View at Google Scholar
  85. P. D. Fan, F. Cong, and S. P. Goff, “Homo- and hetero-oligomerization of the c-Abl kinase and abelson-interactor-1,” Cancer Research, vol. 63, no. 4, pp. 873–877, 2003. View at Google Scholar · View at Scopus
  86. A. R. Salomon, S. B. Ficarro, L. M. Brill et al., “Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 443–448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Innocenti, E. Frittoli, I. Ponzanelli et al., “Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1,” Journal of Cell Biology, vol. 160, no. 1, pp. 17–23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Proepper, S. Johannsen, S. Liebau et al., “Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation,” The EMBO Journal, vol. 26, no. 5, pp. 1397–1409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. X. Xiong, P. Cui, S. Hossain et al., “Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 737–747, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Sato, M. Maruoka, N. Yokota et al., “Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1,” The FEBS Letters, vol. 585, no. 6, pp. 834–840, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. T. P. Cujec, P. F. Medeiros, P. Hammond, C. Rise, and B. L. Kreider, “Selection of v-abl tyrosine kinase substrate sequences from randomized peptide and cellular proteomic libraries using mRNA display,” Chemistry and Biology, vol. 9, no. 2, pp. 253–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. GenBank, CAX15877.1.
  93. P. M. Dubielecka, K. Machida, X. Xiong et al., “Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells,” The FEBS Letters, vol. 584, no. 15, pp. 3279–3286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Filippakopoulos, M. Kofler, O. Hantschel et al., “Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation,” Cell, vol. 134, no. 5, pp. 793–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. S. M. Larson and A. R. Davidson, “The identification of conserved interactions within the SH3 domain by alignment of sequences and structures,” Protein Science, vol. 9, no. 11, pp. 2170–2180, 2000. View at Google Scholar · View at Scopus
  96. Z. Songyang, K. L. Carraway III, M. J. Eck et al., “Catalytic specificity of protein-tyrosine kinases is critical for selective signaling,” Nature, vol. 373, pp. 536–539, 1995. View at Publisher · View at Google Scholar
  97. T. Shishido, T. Akagi, A. Chalmers et al., “Crk family adaptor proteins trans-activate c-Abl kinase,” Genes to Cells, vol. 6, no. 5, pp. 431–440, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Ren, Z. S. Ye, and D. Baltimore, “Ab1 protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites,” Genes and Development, vol. 8, no. 7, pp. 783–795, 1994. View at Google Scholar · View at Scopus
  99. S. M. Feller, B. Knudsen, and H. Hanafusa, “c-Abl kinase regulates the protein binding activity of c-Crk,” The EMBO Journal, vol. 13, no. 10, pp. 2341–2351, 1994. View at Google Scholar · View at Scopus
  100. M. K. Rosen, T. Yamazaki, G. D. Gish, C. M. Kay, T. Pawson, and L. E. Kay, “Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein,” Nature, vol. 374, no. 6521, pp. 477–479, 1995. View at Google Scholar · View at Scopus
  101. G. Sriram, C. Reichman, A. Tunceroglu et al., “Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation,” Oncogene, vol. 30, pp. 4644–4655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. J. H. Jung, A. M. Pendergast, P. A. Zipfel, and J. A. Traugh, “Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK,” Biochemistry, vol. 47, no. 3, pp. 1094–1104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. E. D. Goley and M. D. Welch, “The ARP2/3 complex: an actin nucleator comes of age,” Nature Reviews Molecular Cell Biology, vol. 7, no. 10, pp. 713–726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Takenawa and S. Suetsugu, “The WASP-WAVE protein network: connecting the membrane to the cytoskeleton,” Nature Reviews Molecular Cell Biology, vol. 8, no. 1, pp. 37–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Y. Pollitt and R. H. Insall, “WASP and SCAR/WAVE proteins: the drivers of actin assembly,” Journal of Cell Science, vol. 122, no. 15, pp. 2575–2578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. R. S. Westphal, S. H. Soderling, N. M. Alto, L. K. Langeberg, and J. D. Scott, “Scar/WAVE-1, a Wiskott-Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold,” The EMBO Journal, vol. 19, no. 17, pp. 4589–4600, 2000. View at Google Scholar · View at Scopus
  107. J. R. Stuart, F. H. Gonzalez, H. Kawai, and Z. M. Yuan, “c-Abl interacts with the WAVE2 signaling complex to induce membrane ruffling and cell spreading,” The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31290–31297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. J. E. Bear and F. B. Gertler, “Ena/VASP: towards resolving a pointed controversy at the barbed end,” Journal of Cell Science, vol. 122, no. 12, pp. 1947–1953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Rottner, B. Behrendt, J. V. Small, and J. Wehland, “VASP dynamics during lamellipodia protrusion,” Nature Cell Biology, vol. 1, no. 5, pp. 321–322, 1999. View at Google Scholar · View at Scopus
  110. F. B. Gertler, K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano, “Mena, a relative of VASP and Drosophila enabled, is implicated in the control of microfilament dynamics,” Cell, vol. 87, no. 2, pp. 227–239, 1996. View at Publisher · View at Google Scholar · View at Scopus
  111. F. B. Gertler, J. S. Doctor, and F. M. Hoffmann, “Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog,” Science, vol. 248, no. 4957, pp. 857–860, 1990. View at Google Scholar · View at Scopus
  112. A. R. Comer, S. M. Ahern-Djamali, J. L. Juang, P. D. Jackso, and F. M. Hoffman, “Phosphorylation of enabled by the Drosophila Abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of enabled,” Molecular and Cellular Biology, vol. 18, no. 1, pp. 152–160, 1998. View at Google Scholar
  113. A. K. Howe, B. P. Hogan, and R. L. Juliano, “Regulation of vasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion,” The Journal of Biological Chemistry, vol. 277, no. 41, pp. 38121–38126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. N. L. Zandy, M. Playford, and A. M. Pendergast, “Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 45, pp. 17686–17691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. E. M. Kovacs, M. Goodwin, R. G. Ali, A. D. Paterson, and A. S. Yap, “Cadherin-directed actin assembly: E-cadherin physically associates with the Arp2/3 complex to direct actin assembly in nascent adhesive contacts,” Current Biology, vol. 12, no. 5, pp. 379–382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Brugnera, L. Haney, C. Grimsley et al., “Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex,” Nature Cell Biology, vol. 4, no. 8, pp. 574–582, 2002. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Lu, J. M. Kinchen, K. L. Rossman et al., “PH domain of ELMO functions in trans to regulate Rac activation via Dock180,” Nature Structural and Molecular Biology, vol. 11, no. 8, pp. 756–762, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. N. L. Zandy and A. M. Pendergast, “Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases,” Cell Cycle, vol. 7, no. 4, pp. 444–448, 2008. View at Google Scholar · View at Scopus
  119. S. Eden, R. Rohalgi, A. V. Podelelejnikov, M. Mann, and M. W. Kirschner, “Mechanisms of regulation of WAVE1-induced actin nucleation by Rac1 and Nck,” Nature, vol. 418, no. 6899, pp. 790–793, 2002. View at Google Scholar
  120. M. Innocenti, A. Zucconi, A. Disanza et al., “Abi1 is essential for the formation and activation of a WAVE2 signalling complex,” Nature Cell Biology, vol. 6, no. 4, pp. 319–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Gautreau, H. Y. H. Ho, J. Li, H. Steen, S. P. Gygi, and M. W. Kirschner, “Purification and architecture of the ubiquitous Wave complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4379–4383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Derivery and A. Gautreau, “Generation of branched actin networks: assembly and regulation of the N-WASP and WAVE molecular machines,” BioEssays, vol. 32, no. 2, pp. 119–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. Z. Chen, D. Borek, S. B. Padrick et al., “Structure and control of the actin regulatory WAVE complex,” Nature, vol. 468, no. 7323, pp. 533–538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. W. A. Kheir, J. C. Gevrey, H. Yamaguchi, B. Isaac, and D. Cox, “A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages,” Journal of Cell Science, vol. 118, no. 22, pp. 5369–5379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. P. A. Zipfel, S. C. Bunnell, D. S. Witherow et al., “Role for the Abi/Wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling,” Current Biology, vol. 16, no. 1, pp. 35–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Innocenti, S. Gerboth, K. Rottner et al., “Abi1 regulates the activity of N-WASP and WAVE in distinct actin-based processes,” Nature Cell Biology, vol. 7, pp. 969–976, 2005. View at Publisher · View at Google Scholar
  127. M. Maruoka, M. Sato, Y. Yuan et al., “Abi-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukemic cell adhesion,” Biochemical Journal, vol. 441, no. 3, pp. 889–999, 2012. View at Publisher · View at Google Scholar
  128. A. Fujita, T. Shishido, Y. Yuan, E. Inamoto, S. Narumiya, and N. Watanabe, “Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective abelson kinase: requirements of myristoylation and src homology 3 domain,” Molecular Pharmacology, vol. 75, no. 1, pp. 75–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. N. Hirao, S. Sato, T. Gotoh et al., “NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation,” The FEBS Letters, vol. 580, no. 27, pp. 6464–6470, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. G. Bazzoni, N. Carlesso, J. D. Griffin, and M. E. Hmler, “Bcr/Abl expression stimulates integrin function in hematopoietic cell line,” Journal of Clinical Investigation, vol. 98, no. 2, pp. 521–528, 1996. View at Publisher · View at Google Scholar
  131. Y. Li, N. Clough, X. Sun et al., “Bcr-Abl induces abnormal cytoskeletal remodeling, beta 1 interin clustering and increase cell adhesion to fibronectin through the Abl interactor 1 pathway,” Journal of Cell Science, vol. 120, pp. 1436–1446, 2007. View at Google Scholar
  132. W. Yu, X. Sun, N. Clough, E. Cobos, Y. Tao, and Z. Dai, “Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo,” Carcinogenesis, vol. 29, no. 9, pp. 1717–1724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. X. Sun, Y. Li, W. Yu, B. Wang, Y. Tao, and Z. Dai, “MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration,” Leukemia, vol. 22, no. 5, pp. 1053–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Sharma and B. J. Mayer, “Phosphorylation of p130Cas initiates Rac activation and membrane ruffling,” BMC Cell Biology, vol. 9, article 50, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. M. D. Schaller and J. T. Parsons, “pp125(FAK)-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk,” Molecular and Cellular Biology, vol. 15, no. 5, pp. 2635–2645, 1995. View at Google Scholar · View at Scopus
  136. C. E. Turner, “Paxillin and focal adhesion signalling,” Nature Cell Biology, vol. 2, no. 12, pp. E231–E236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  137. J. M. Lewis and M. A. Schwartz, “Integrins regulate the association and phosphorylation of paxillin by c- Abl,” The Journal of Biological Chemistry, vol. 273, no. 23, pp. 14225–14230, 1998. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Chen, R. Wang, Q. F. Li, and D. D. Tang, “Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice,” American Journal of Physiology, vol. 297, no. 2, pp. H533–H539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. T. Takino, M. Tamura, H. Miyamori et al., “Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration,” Journal of Cell Science, vol. 116, pp. 3145–3155, 2003. View at Google Scholar
  140. R. L. Klemke, J. Leng, R. Molander, P. C. Brooks, K. Vuori, and D. A. Cheresh, “CAS/Crk coupling serves as a “molecular switch” for induction of cell migration,” Journal of Cell Biology, vol. 140, pp. 961–972, 1998. View at Google Scholar
  141. K. H. Kain and R. L. Klemke, “Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes,” The Journal of Biological Chemistry, vol. 276, no. 19, pp. 16185–16192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. H. Hu, J. M. Bliss, Y. Wang, and J. Colicelli, “RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration,” Current Biology, vol. 15, no. 9, pp. 815–823, 2005. View at Publisher · View at Google Scholar · View at Scopus